Literature DB >> 6993270

A new mutation (db3J) at the diabetes locus in strain 129/J mice. II. Studies of pancreatic alpha cell function in culture.

E H Leiter, I Strack, A B Eisenstein.   

Abstract

Monolayer cell cultures from pancreatic islets of aging 129/J strain diabetes (db3J/db3J) and lean littermate control mice were tested for differences in glucagon and insulin secretion in either serum-free Eagle's minimal essential medium (MEM) or Dulbecco's modified minimal essential medium (DMEM). There was a highly significant (p less than 0.0001) main effect of genotype and type of culture medium on glucagon secretion with time. Thus, although numbers of A-cells were not demonstrably increased in db3J/db3J cultures in DMEM, mean medium glucagon levels increased 2.7-, 18-, and 32-fold above littermate normal culture levels at days 4, 6, and 8 respectively. In MEM, the two populations could not be discriminated on the basis of glucagon secretion. By contrast, insulin secretion over culture days showed a highly significant (p less than 0.0001) dependence on genotype, but not type of medium, with the B-cell enriched db3J/db3J preparations secreting between 20 and 30 times as much insulin as controls in both medida. Analysis revealed that the heightened secretory responsiveness of mutatn A-cells in DMEM as compared to MEM was primarily elicited by the elevated DMEM amino acid concentration and specifically lysine (0.8 mmol/l in DMEM versus 0.4 mmol/l in MEM). In pulse-chase experiments using 14 day db3J/db3J cultures, incorporation of 3H-tryptophan into protein that eluted from Biogel P-10 columns in the native glucagon peak indicates that DMEM stimulated glucagon biosynthesis as well as secretion. This study reveals an augmented sensitivity of db3J/db3J A-cells to stimulation by basic amino acids in long-term culture.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993270     DOI: 10.1007/bf00258314

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Fetal bovine serum: a multivariate standard.

Authors:  K V Honn; J A Singley; W Chavin
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

2.  Activity of (Na+ + K+)-ATPase in the liver of animals with experimental obesity.

Authors:  G A Bray; Y Yukimura
Journal:  Life Sci       Date:  1978-05-08       Impact factor: 5.037

3.  Function of microdissected pancreatic islets cultured in a chemically defined medium. I. Insulin content and release.

Authors:  A Buitrago; E Gylfe; B Hellman; L A Idahl; M Johansson
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

4.  Establishment of serum based essentiall free of proteolytic activity for the culture of mouse pancreatic islets.

Authors:  M Kedinger; A Moody; J F Launay; K Haffen
Journal:  Experientia       Date:  1977-07-15

5.  Hyperinsulinemia in pre-weaning diabetes (db) mice.

Authors:  D L Coleman; K P Hummel
Journal:  Diabetologia       Date:  1974-11       Impact factor: 10.122

Review 6.  Tissue culture of isolated pancreatic islets.

Authors:  A Andersson
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1976

7.  Effect of glucose and amino acids on foetal rat pancreatic growth and insulin secretion in vitro.

Authors:  M de Gasparo; G R Milner; P D Norris; R D Milner
Journal:  J Endocrinol       Date:  1978-05       Impact factor: 4.286

8.  Intracisternal A-particles in genetically diabetic mice: identification in pancreas and induction in cultured beta cells.

Authors:  E H Leiter; H G Bedigian
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

9.  Glucagon and insulin relationships in genetically diabetic (db/db) and in streptozotocin-induced diabetic mice.

Authors:  S B Stearns; C A Benzo
Journal:  Horm Metab Res       Date:  1978-01       Impact factor: 2.936

10.  A new mutation (db3J) at the diabetes locus in strain 129/J mice. I. Physiological and histological characterization.

Authors:  E H Leiter; D L Coleman; A B Eisenstein; I Strack
Journal:  Diabetologia       Date:  1980-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.